Many mutations have been found in disease-responsible genes. Frameshift mutations alter the reading frame, thus inducing a completely different translation from the original one, and often inactivate genes by producing truncated, nonfunctional proteins, resulting in the onset of diseases. For example, Duchenne muscular dystrophy is caused by mutations, mainly frameshifts, in the dystrophin (DMD) gene.
1)Thus, frameshift mutations are interesting targets for gene correction, conversion of a mutated sequence to the normal one.Chemically synthesized oligonucleotides and polymerase chain reaction (PCR) fragments have been used as nucleic acids for gene correction.2-7) We previously reported that a single-stranded (ss) DNA fragment containing the sense sequence, and tailed duplex (TD) DNA fragments prepared by annealing an oligonucleotide to the ss DNA fragment, have the ability to correct single-base substitution mutations. [8][9][10] However, the ss DNA fragment corrects frameshift (singlebase deletion and single-base insertion) mutations with low efficiencies.11) Since the correction efficiencies of single-base substitution mutations by the TD fragments are higher than those by the ss DNA fragment, 10) it is important to examine the ability of the TD fragments to correct frameshift mutations.In this study, we determined the efficiency of frameshift mutation correction by the TD DNA fragments. Episomal hygromycin-resistance (Hyg) and enhanced green fluorescent protein (EGFP) fusion genes, inactivated by single-base deletion and insertion mutations, were chosen as model targets. The TD fragments were co-introduced into CHO-K1 cells with a plasmid DNA carrying the target gene. The gene correction efficiency was quantitatively determined by counting the EGFP-positive and hygromycin-resistant Escherichia coli colonies, after recovering the plasmid DNA from the transfected cells and introducing it into bacterial cells. The results obtained in this study suggested that the TD fragments have the potential to correct frameshift mutations, although further improvements are necessary for their clinical use.
MATERIALS AND METHODS
GeneralThe pTENHEins, pTENHEdel, and pTENHEX plasmids and the pBSHES/Sense phagemid were the same DNAs described in our previous studies. 8,11) The plasmid DNAs were amplified in E. coli strain DH5a, and were purified with a Qiagen (Hilden, Germany) Endofree Plasmid Mega kit. Oligodeoxyribonucleotides were purchased from Sigma Genosys Japan (Ishikari, Japan) and Hokkaido System Science (Sapporo, Japan) in purified forms. Helper phage VCSM13 and E. coli strain BL21(DE3) were from Agilent Technologies (Santa Clara, CA, U.S.A.).Preparation of DNA Fragments for Gene Correction The 606-base ss sense fragment was prepared from the ss pBSHES/Sense phagemid DNA, by annealing with its respective scaffold oligodeoxyribonucleotides followed by XhoI digestion, as described previously.8) The DNA fragment was purified by low-melting point agarose gel electrophoresis and gel filtration chromatography. Its UV spectr...